- Home
- RPRX vs NVMI Comparison
RPRX vs NVMI Comparison
Compare RPRX & NVMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | NVMI |
|---|---|---|
| Founded | 1996 | 1993 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.7B | 13.7B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RPRX | NVMI |
|---|---|---|
| Price | $40.54 | $464.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $45.75 | ★ $372.14 |
| AVG Volume (30 Days) | ★ 3.4M | 352.7K |
| Earning Date | 02-11-2026 | 02-12-2026 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | N/A | ★ 44.31 |
| EPS | 1.75 | ★ 7.71 |
| Revenue | ★ $2,349,844,000.00 | $852,719,000.00 |
| Revenue This Year | $37.66 | $33.32 |
| Revenue Next Year | $2.34 | $10.23 |
| P/E Ratio | ★ $23.06 | $59.78 |
| Revenue Growth | 3.70 | ★ 39.37 |
| 52 Week Low | $29.66 | $154.00 |
| 52 Week High | $41.70 | $475.00 |
Technical Indicators
Market Signals| Indicator | RPRX | NVMI |
|---|---|---|
| Relative Strength Index (RSI) | 59.05 | 79.90 |
| Support Level | $38.86 | $436.33 |
| Resistance Level | $40.58 | $475.00 |
| Average True Range (ATR) | 0.76 | 15.44 |
| MACD | 0.01 | 5.67 |
| Stochastic Oscillator | 58.63 | 90.76 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About NVMI Nova Ltd.
Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.